Finance

Lists
Q2 2026 earnings • released • EPS beat +2.75% • Revenue beat +1.40%
See results
CME:NASDAQ
CME Group Inc
$255.31
+0.39%
(+0.99) 1D
Jul 24, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CME...
Open
$254.20
High
$256.16
Low
$251.34
Mkt. cap
92.51B
Avg. vol.
3.74M
Volume
1.81M
Dividend
2.04%
Quarterly dividend
$1.30
Ex-dividend date
Jun 9, 2026
P/E ratio
21.58
52-wk high
$329.16
52-wk low
$218.31
EPS
$11.83
Beta
0.23
Shares outstanding
362.36M
No. of employees
4K
Open
$254.20
High
$256.16
Low
$251.34
Mkt. cap
92.51B
Avg. vol.
3.74M
Volume
1.81M
Dividend
2.04%
Quarterly dividend
$1.30
Ex-dividend date
Jun 9, 2026
P/E ratio
21.58
52-wk high
$329.16
52-wk low
$218.31
EPS
$11.83
Beta
0.23
Shares outstanding
362.36M
No. of employees
4K
News stories
From sources across the web
Profile
CME Group Inc., headquartered in Chicago, Illinois, operates exchanges and provides clearing services for trading in financial derivatives such as futures contracts, options, and swaps. Its exchanges include the Chicago Mercantile Exchange, the Chicago Board of Trade, the New York Mercantile Exchange, and the Commodity Exchange. The company also owns 27% of S&P Dow Jones Indices. The company operates the Globex Trading System, an electronic trading platform that allows customers in approximately 150 countries to trade futures and options contracts. The company also operates two platforms for spot market trading: BrokerTec, which facilitates dealer-to-dealer trading in fixed-income products, and EBS, which provides spot trading in foreign exchange markets. CME Clearing serves as a counterparty to every transaction cleared by the company. Financial derivatives traded on CME's exchanges are tied to interest rates, stock market indexes, energy-related products, agricultural products, exchange currencies, metals, and cryptocurrency. Institutional trading represents 85% to 90% of the company's trading volume. Wikipedia
About CME Group Inc
CEOTerrence A. Duffy
Employees3.88K
FoundedJul 12, 2007
HeadquartersChicago, Illinois, United States
SectorCapital market
Websitecmegroup.com
Analyst ratings
Based on 12 analysts giving stock ratings to CME in the past 3 months
Hold
Buy
5
Hold
4
Sell
3
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for CME in the last 3 months.
Highest
Current $255.31
$330.00 (+29.25%)
Average
$278.27 (+8.99%)
Lowest
$230.00 (-9.91%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ken Worthington
J.P. Morgan
Sell
Maintained
$250.00
-2.1%
07/23/2026
Ashish Sabadra
RBC Capital
Hold
Maintained
$302.00
+18.3%
07/22/2026
Alex Kramm
UBS
Hold
Maintained
$260.00
+1.8%
07/23/2026
Patrick Moley
Piper Sandler
Buy
Reiterated
$295.00
+15.5%
07/23/2026
Damon Delmonte
KBW
Buy
Maintained
$285.00
+11.6%
07/23/2026
Michael Cyprys
Morgan Stanley
Buy
Reiterated
$330.00
+29.3%
07/23/2026
Craig Siegenthaler
Bank of America Securities
Sell
Reiterated
$230.00
-9.9%
07/22/2026
Benjamin Budish
Barclays
Hold
Maintained
$270.00
+5.8%
07/23/2026
Alexander Blostein
Goldman Sachs
Sell
Maintained
$243.00
-4.8%
07/14/2026
Hans Engel
Erste Group
Hold
Maintained
-
-
06/24/2026
William Katz
TD Cowen
Buy
Maintained
$273.00
+6.9%
06/22/2026
Christopher Allen
KBW
Buy
Upgraded
$305.00
+19.5%
06/17/2026
Simon Clinch
Rothschild & Co Redburn
Buy
Upgraded
$323.00
+26.5%
06/11/2026
Kyle Voigt
KBW
Hold
Initiated
$305.00
+19.5%
04/08/2026
Unknown Analyst
Goldman Sachs
Sell
Maintained
$275.00
+7.7%
04/06/2026
Kevin Heal
Argus Research
Hold
Downgraded
-
-
03/03/2026
Last report
Jul 22, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$2.99 / $2.91
+2.75%beat
Revenue / Est. (USD)
1.71B / 1.68B
+1.40%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.53B
1.64B
1.88B
1.71B
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
440.00M
473.10M
446.60M
455.00M
Operating expense
561.80M
595.10M
566.50M
599.10M
Total operating expenses
561.80M
595.10M
566.50M
599.10M
Operating income
972.60M
1.05B
1.31B
1.11B
Other non operating income
-1.40B
-1.28B
-1.25B
-1.26B
EBT including unusual items
1.18B
1.58B
1.51B
1.33B
EBT excluding unusual items
1.18B
1.56B
1.51B
1.33B
Income tax expense
269.00M
395.50M
356.60M
285.90M
Effective tax rate
22.85%
25.06%
23.60%
21.53%
Other operating expenses
39.20M
39.60M
36.60M
59.90M
Net income
908.00M
1.18B
1.15B
1.04B
Net profit margin
59.18%
71.94%
61.52%
61.06%
Earnings per share
2.68
2.77
3.36
2.99
Interest and investment income
1.55B
1.78B
1.39B
1.43B
Interest expense
-44.00M
-43.70M
-43.60M
-43.60M
Net interest expenses
1.50B
1.73B
1.35B
1.39B
Depreciation and amortization charges
26.40M
26.50M
27.20M
28.20M
EBITDA
1.06B
1.13B
1.39B
1.19B
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer